medigraphic.com
ISSN 2007-6800 (Print)

2021, Number 1

<< Back Next >>

Rev Mex Traspl 2021; 10 (1)

Epidemiologic impact of COVID-19 over donation and transplantation programs in San Luis Potosi, Mexico

Monsiváis-Santoyo TG, Gámez-Gómez E

Language: Spanish
References: 17
Page: 12-16
PDF size: 231.87 Kb.


ABSTRACT

Introduction: Currently there are no reports of transmission of COVID-19 related to organ transplantation. The current COVID-19 pandemic has created significant challenges for our healthcare system, specially for healthcare professionals, with prominent repercussions on organ and tissue donation and transplant programs observed during the pandemic in the programs of donation and transplant in the country San Luis Potosí. The aim of this study is to prove the impact of the coronavirus pandemic in the program of donation and transplant. Material and methods: The database of the files of the computer System Platform of the National Transplant Registry (SIRNT) with the data of San Luis Potosí was reviewed during the period from 2015 to 2020. The transplant activities during the previous years were compared with those carried out in 2020. Results: During the period covered, 962 transplants were performed in the state of San Luis Potosí, of which 408 were kidney (42.4%), 554 were corneal (57.5%). 156 transplants of cadaveric origin (37.2%) and 252 of living (61.7%) were performed. From the transplants performed, 421 were performed in women (43.7%). Conclusions: There was no difference in the incidence between cadaveric and living kidney donors during the period analyzed.


REFERENCES

  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506. http://dx.doi.org/10.1016/S0140-6736(20)30183-5.

  2. World Health Organization. Novel coronavirus situation report 2 [Internet]. 2020. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov.pdf?sfvrsn=4d5bcbca_2

  3. López V, Vázquez T, Alonso-Titos J, Cabello M, Alonso A, Beneyto I et al. Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (COVID-19) en pacientes con trasplante renal. Nefrologia. 2020; 40 (3): 265-271.

  4. Coll E, Gayoso J, Martínez JR, Domínguez B. Informe Casos COVID-19 en pacientes trasplantados. Organización Nacional de Trasplantes. 2020. Disponible en: https://www,seden.org7files7news7INFORME%20CASOS%20COVID%2019%20EN%20PACIENTES%20TRASPLANTADOS%20%2018%20MAYOb5f4.pdf

  5. Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ et al. Solid-organ transplantation in older adults: current status and future research. Am J Transplant. 2012; 12: 2608-2622. http://dx.doi.org/10.1111/j.1600-6143.2012.

  6. Roger M, Sierra-Ruiz M, Barrera-Lozano LM. Organ donation and transplantation in the COVID-19 era: should programs really stop? Rev Colomb Cir. 2020; 35: 227-234.

  7. Secretaría de Salud-Centro Nacional de Trasplantes. Plan Nacional de Reactivación de los Programas de Donación y Trasplantes. Gobierno de México. 2020. Disponible en: https://www.gob.mx/cenatra/es/documentos/plan-nacional-de-reactivacion-de-los-programas-de-donacion-y-trasplantes-246588?state=published

  8. Martin R, Sierra-Ruiz M, Barrera-Lozano LM. Donación de órganos y trasplante en la era COVID-19: ¿Realmente se deben parar los programas? Rev Colomb Cir. 2020; 35: 227-234.

  9. Daga Ruiz D, Fernández Aguirre C, Segura González F, Carballo Ruiz M. Indicaciones y resultados a largo plazo de los trasplantes de órganos sólidos: Calidad de vida en pacientes trasplantados. Med Intensiva. 2008; 32 (6): 296-303.

  10. Martino F, Plebani M, Ronco C. Kidney transplant programmes during the COVID-19 pandemic. Lancet Respir Med. 2020; 8 (5): e39. doi: 10.1016/S2213-2600(20)30182-X.

  11. Domínguez-Gil B, Coll E, Ferrer-Fabrega J, Briceño J, Ríos A. Dramatic impact of the COVID-19 outbreak on donation and transplantation activities in Spain. Cir Esp. 2020; 98 (7): 412-414.

  12. Documento Técnico. Manejo clínico de pacientes con enfermedad por el nuevo coronavirus (COVID-19). Centro de Coordinación de Alertas y Emergencias Sanitarias. Dirección General de Salud Pública, Calidad e Innovación. Ministerio de Sanidad; 3 de marzo de 2020.

  13. Aburto-Morales JS, Romero-Méndez J, Lucio-García CA, Madrigal-Bustamante JA. México ante la epidemia de COVID-19 (SARS-CoV-2) y las recomendaciones al Subsistema Nacional de Donación y Trasplante. Rev Mex Traspl. 2020; 9 (1): 6-14.

  14. Garbino J, Crespo S, Aubert JD, Rochat T, Ninet B, Deffernez C et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin Infect Dis. 2006; 43 (8): 1009-1015. doi: 10.1086/507898.

  15. Sánchez-Cedillo A, Cruz-Santiago J, Mariño-Rojas FB, Hernández-Estrada S, García-Ramírez C. Carga de la enfermedad: insuficiencia renal, diálisis-hemodiálisis y trasplante renal en México. Costo de la enfermedad. Rev Mex Traspl. 2020; 9 (1): 15-25.

  16. Michaels MG, La Hoz RM, Danziger-Isakov L, Blumberg EA, Kumar D, Green M et al. Coronavirus disease 2019: implications of emerging infections for transplantation. Am J Transplant. 2020; 20 (7): 1768-1772.

  17. Villaseñor-Colín C. Principales aspectos quirúrgicos de procuración multiorgánica de donador cadavérico en la contingencia sanitaria por COVID-19. Med Int Mex. 2020; 36 (Suppl: 2): 66-69.




2020     |     www.medigraphic.com